e-learning
resources
Barcelona 2013
Tuesday, 10.09.2013
New evidence for NIV in the acute setting
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Do patients with recurrent exacerbations of COPD requiring NIV receive higher pressures than those that are NIV naive?
E. A. Benison, W. Y. Ding, E. Houston, M. Murthy, R. Yadavilli, H. Burhan (Liverpool, United Kingdom)
Source:
Annual Congress 2013 –New evidence for NIV in the acute setting
Session:
New evidence for NIV in the acute setting
Session type:
Poster Discussion
Number:
4751
Disease area:
Airway diseases, Respiratory critical care
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. A. Benison, W. Y. Ding, E. Houston, M. Murthy, R. Yadavilli, H. Burhan (Liverpool, United Kingdom). Do patients with recurrent exacerbations of COPD requiring NIV receive higher pressures than those that are NIV naive?. Eur Respir J 2013; 42: Suppl. 57, 4751
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Lane-hamilton syndrome and CCF: a fatal association
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Predictors of poor outcome in patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) receiving noninvasive positive pressure ventilation (NPPV
Source: International Congress 2015 – Outcome of noninvasive ventilatory support in acute and chronic respiratory failure
Year: 2015
Characterization of readmissions in patients hospitalized with COPD exacerbation
Source: International Congress 2016 – Novel avenues in the treatment of COPD II
Year: 2016
Predictors of survival in severe COPD patients initiated on chronic NIV
Source: International Congress 2016 – New horizons for noninvasive ventilation in acute and chronic settings
Year: 2016
COPD patients admitted in ICU for acute exacerbation: Impact of exacerbation factors on prognosis
Source: International Congress 2016 – Dealing with the complexity of critically-ill patients
Year: 2016
Exacerbation and hospitalization in COPD patients with long-term high-intensity NPPV
Source: Annual Congress 2007 - Technological progress in noninvasive ventilation
Year: 2007
Prognosis and evolution of COPD patients hospitalized and treated with non invasive ventilation
Source: Annual Congress 2013 –New evidence for NIV in the acute setting
Year: 2013
Recording and response to hyperglycaemia in patients presenting with infective exacerbations of COPD
Source: Annual Congress 2013 –Difficult and rare respiratory infections
Year: 2013
Is restricted transfusion approach in the ICU appropriate also for COPD exacerbations?
Source: International Congress 2015 – Acute critical care: news from the ICU
Year: 2015
Predictors of readmission after hospitalization for acute exacerbations of chronic obstructive pulmonary disease (AECOPD)
Source: Annual Congress 2013 –COPD: markers and inflammation
Year: 2013
Risk factors for another hospitalization in COPD patients hospitalized for exacerbation
Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases
Year: 2016
Real-life experience of older patients requiring NIV for exacerbations of chronic obstructive pulmonary disease
Source: Annual Congress 2009 - New trends in noninvasive ventilation for acute respiratory failure
Year: 2009
QVA149 reduces COPD exacerbation rate in various subgroups of patients: The SPARK study
Source: Annual Congress 2013 –New bronchodilators for COPD management
Year: 2013
Rehospitalizations for an acute exacerbation among patients with COPD
Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD
Year: 2015
PAP therapy impact on COPD exacerbations rate in patients with overlap syndrome
Source: International Congress 2015 – To treat or not to treat, and how? Sleep-disordered breathing I
Year: 2015
COPD on anti-GERD therapy remains at higher risk for severe exacerbation
Source: International Congress 2014 – COPD exacerbations
Year: 2014
Factors associated with exacerbation in a general practitioners’-based Swiss chronic obstructive pulmonary disease (COPD) cohort
Source: Annual Congress 2013 –The best posters in chronic care
Year: 2013
Effect of exacerbation history and ICS use on outcomes in COPD patients from the TIOSPIR™ trial
Source: International Congress 2015 – New data on established treatments for COPD
Year: 2015
May the obesity cause a better prognosis for domiciliary NIV prescribed COPD patients?
Source: International Congress 2015 – Outcome of noninvasive ventilatory support in acute and chronic respiratory failure
Year: 2015
Frequency of COPD exacerbations and severity of COPD
Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept